In most cases, the only way for adults or children to stop the rebound effect is to stop taking the offending medication. This, however, should be done under a physician's care since it usually results in a severe withdrawal headache that may be accompanied by nausea, vomiting, restlessness, and disturbed sleep.
About LipiGesic M:Results of a double-blind, placebo-controlled clinical trial for LipiGesic M show LipiGesic M is a highly effective treatment for acute migraine. The study was published in the July 2011 issue of the top-tier medical journal, Headache: The Journal of Head and Face Pain. LipiGesic M has national distribution and is available nationwide in Walgreens and CVS/pharmacy stores nationwide. In addition to LipiGesic M, the Company also has plans to launch LipiGesic H, tension headache remedy, as well as LipiGesic PM, a remedy for insomnia and other sleep disorders. www.lipigesic.com
As of August 01, 2013, the Company currently had around 43 million common shares issued and outstanding.
Forward-Looking Statements:This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.Contact:PuraMed BioScience, Inc. Russell Mitchell, Chairman and CEO715-359-6373 rmitchell@PuramedBioScience.com www.PuramedBioScience.com SOURCE PuraMed BioScience, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts